The European Medicines Agency said Thursday that its committee evaluating medical products has recommended partial approval ...
MEDIA RELEASEAfqlir® (aflibercept) approved to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD)One ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback